BIOSECURE Act
- Introduced May 10
- Committee May 10
- Passed House Sep 9
- Passed Senate Next
- To President Not yet
- Law Not yet
Companies lobbying on this bill
4 companiesVotes
Member trades
No member of Congress traded these companies within 90 days of a vote
Summary
BIOSECURE Act
Full summary4 paragraphs
This bill prohibits entities that receive federal funds from using biotechnology that is from a company associated with a foreign adversary.
Specifically, federal agencies and recipients of federal funds (e.g., grantees) may not procure or use any biotechnology equipment or service that is from a biotechnology company of concern and may not contract with any entities that do so. A biotechnology company of concern is an entity that is under the control of a foreign adversary and that poses a risk to national security based on its research or multiomic data collection (e.g., collection of genomic information).
The Office of Management and Budget (OMB) must, in coordination with the Department of Defense (DOD) and other specified agencies, develop a list of prohibited companies; the list must include five particular companies, as specified in the bill. OMB and DOD may approve waivers of these restrictions on an as-needed basis, which are valid for up to one year and may be extended once for an additional 180 days.
In addition, the Office of the Director of National Intelligence must report on the national security risks posed by (1) multiomic data collection by foreign adversaries in connection with biotechnology equipment or services, and (2) biotechnology companies that have such data.
Library of Congress summary, May 10, 2024
- Introduced in HouseMay 10, 2024
Actions
- SenateReceived in the Senate and Read twice and referred to the Committee on Homeland Security and Governmental Affairs.Sep 10, 2024
- HouseMotion to reconsider laid on the table Agreed to without objection.Sep 9, 2024
- HouseOn motion to suspend the rules and pass the bill, as amended Agreed to by the Yeas and Nays: (2/3 required): 306 - 81 (Roll no. 402). (text: CR H5051-5052)Sep 9, 2024
- HouseConsidered as unfinished business. (consideration: CR H5081-5082)Sep 9, 2024
- HouseAt the conclusion of debate, the Yeas and Nays were demanded and ordered. Pursuant to the provisions of clause 8, rule XX, the Chair announced that further proceedings on the motion would be postponed.Sep 9, 2024
- HouseDEBATE - The House proceeded with forty minutes of debate on H.R. 8333.Sep 9, 2024
- HouseConsidered under suspension of the rules. (consideration: CR H5051-5058)Sep 9, 2024
- HouseMr. Comer moved to suspend the rules and pass the bill, as amended.Sep 9, 2024
- HouseCommittee Consideration and Mark-up Session HeldMay 15, 2024
- HouseOrdered to be Reported in the Nature of a Substitute by the Yeas and Nays: 40 - 1.May 15, 2024
- HouseIntroduced in HouseMay 10, 2024
- HouseReferred to the Committee on Oversight and Accountability, and in addition to the Committee on Intelligence (Permanent Select), for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.May 10, 2024
Bill record
Text versions3
- Referred in SenateSep 10, 2024PDF: Referred in Senate
- Engrossed in HouseSep 9, 2024PDF: Engrossed in House
- Introduced in HouseMay 10, 2024PDF: Introduced in House
Committees3
- Senate Homeland Security and Governmental Affairs CommitteeReferred To Sep 10, 2024
- House Oversight and Government Reform CommitteeMarkup By May 15, 2024Referred To, May 10, 2024
- House Intelligence (Permanent Select) CommitteeReferred To May 10, 2024
Sponsor and cosponsors14 cosponsors
- Rep. Brad Wenstrup (R-OH-2)Sponsor, May 10, 2024
- Anna Eshoo (D-CA-16)OriginalJoined May 10, 2024
- Donald Davis (D-NC-1)OriginalJoined May 10, 2024
- Elise Stefanik (R-NY-21)OriginalJoined May 10, 2024
- John Moolenaar (R-MI-2)OriginalJoined May 10, 2024
- Neal Dunn (R-FL-2)OriginalJoined May 10, 2024
- Raja Krishnamoorthi (D-IL-8)OriginalJoined May 10, 2024
- Seth Moulton (D-MA-6)OriginalJoined May 10, 2024
- Ashley Hinson (R-IA-2)Joined May 14, 2024
- Elissa Slotkin (D-MI-7)Joined May 14, 2024
- Josh Gottheimer (D-NJ-5)Joined May 21, 2024
- Stephanie Bice (R-OK-5)Joined May 21, 2024
- Darin LaHood (R-IL-16)Joined Jul 8, 2024
- Thomas Suozzi (D-NY-3)Joined Jul 8, 2024
- Mark Green (R-TN-7)Joined Sep 9, 2024
Amendments0
No amendments offered
Cost estimates and reports1
- CBO: H.R. 8333, BIOSECURE ActJun 25, 2024As ordered reported by the House Committee on Oversight and Accountability on May 15, 2024
Titles2
- BIOSECURE ActShort Titles from RFS (Referred to Senate) bill text
- To prohibit contracting with certain biotechnology providers, and for other purposes.Official Title as Introduced
Subjects12
Related bills1
- S. 3558 118th, Related bill Prohibiting Foreign Access to American Genetic Information Act of 2024
Official record from Congress.gov, the House Clerk and the Senate; lobbying from Lobbying Disclosure Act filings. Updated Oct 28, 2026.